Clinical Trial Update: Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effects of renin-angiotensin system blockade on clinical evolution and ventricular remodeling after transcatheter aortic va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Transcatheter Aortic Valve Implantation Complications

Snippet

Sponsor: Hospital Clínico Universitario de Valladolid | Conditions: Transcatheter Aortic Valve Replacemen, Angiotensin-Converting Enzyme Inhibitors | Phase 4 | Status: UNKNOWN